RecruitingNot ApplicableNCT06165510

Convergent Ablation Plus Left Atrial Appendage Isolation for the Treatment of Persistent Atrial Fibrillation


Sponsor

Barts & The London NHS Trust

Enrollment

48 participants

Start Date

Aug 2, 2024

Study Type

INTERVENTIONAL

Conditions

Summary

A randomised controlled clinical trial to assess efficacy of convergent ablation with the LARIAT procedure, as compared to standard endocardial catheter ablation in patients with long-standing persistent atrial fibrillation (AF).


Eligibility

Min Age: 18 YearsMax Age: 80 Years

Plain Language Summary

Simplified for easier understanding

This study tests whether "convergent ablation" — combining a minimally invasive procedure inside the heart with one on the outside — along with isolating the left atrial appendage (a small pouch in the heart) can reduce or eliminate persistent atrial fibrillation (irregular heartbeat) better than current techniques alone. **You may be eligible if...** - You are an adult with persistent or long-standing persistent atrial fibrillation (AFib) that has not responded to prior treatments - You have failed at least one prior catheter ablation or are not a candidate for standard ablation alone - Your heart function is adequate for the procedure **You may NOT be eligible if...** - You have a blood clot in the heart's left atrial appendage - You have had recent major cardiac surgery - You have severe valve disease or other conditions making the procedure unsafe - You are pregnant Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEEpicardial AF ablation using AtriCure EPi-Sense-AF Guided Coagulation System with Left Atrial Appendage Exclusion using the AtriCure LARIAT Suture Delivery Device.

2 stage procedure - minimally-invasive epicardial ablation with left atrial appendage exclusion using LARIAT procedure via a subxiphoid incision. This is then combined with endocardial radiofrequency catheter ablation in a separate staged procedure.

PROCEDUREStandard Endocardial Catheter Ablation

Standard percutaneous endocardial catheter ablation of atrial fibrillation


Locations(1)

St Bartholomew's Hospital

London, United Kingdom

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06165510


Related Trials